-
2026-08-13
GenSci's Ophthalmology Pipeline: IND Approval Secured for Three IndicationsLearn More
-
2026-07-31
GenSci144, a Novel SLC6A19 Inhibitor, Receives IND Approval from NMPALearn More
-
2026-07-30
Gensci's VEGFR2 mAb NDA Accepted by NMPALearn More
-
2026-07-30
GenSci098 Receives FDA Fast Track Designation and Advances into Phase 2 Clinical TrialsLearn More
-
2024-11-07
Welcome to Visit Us at MEDICA 2024Learn More
-
2024-10-25
GenSci' s Inaugural R&D Day 2024: Innovation in Gene, Science in Actionsuccessfully concluded on October 17, 2024
Learn More
-
2024-09-24
Meet GenSci at CPhI Milan 2024Learn More
-
2024-09-23
GenSci showcases the innovative pipelines at ChinaBio®Learn More
-
2024-09-03
GenSci Invites You to Meet Us at Pharmedi Vietnam 2024Learn More
-
2024-08-29
GenSci098 Injection Obtains Implied License For Clinical Trials of FDALearn More